Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive ...

The recall involves Veklury for Injection with Lot #47035CFA (NDC # 61958-2901-02) and an expiration date of November 2025. Gilead is voluntarily recalling 1 lot of Veklury ® (remdesivir) for ...

Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...

Pieces of glass have been discovered in an injection vial from the Ratnapura Hospital, while a dust-like substance has been discovered in another injection vial from the Padukka Hospital. The Health ...

One lot of an injection drug meant to help patients deal with leukemia has been recalled on concerns it might damage or kill the patient. That’s not overstatement, but, rather, the summary of the ...

Investment increases production in Wertheim by 150 million vials and creates 70 new jobs Next step on the way to becoming the world's leading producer of glass vials CEO Siemssen: "Consistent ...

No complications were found in a retrospective review of 135 patients who received 574 bilateral same-day intravitreal injections from a single vial with separate syringes or needles for a host of ...

Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 ...